BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 33720565)

  • 1. [Asthma exacerbation due to preoperative NSAID use].
    Miry T; van der Sar-van der Brugge S; van der Rijt AJM
    Ned Tijdschr Geneeskd; 2021 Mar; 165():. PubMed ID: 33720565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Aspirin-Exacerbated Respiratory Disease and Atherosclerotic Cardiovascular Disease: A Retrospective Review of US Claims Data.
    Adame MJ; Raji M; Shan Y; Zhang Y; Kuo YF; Tripple JW
    J Allergy Clin Immunol Pract; 2023 Nov; 11(11):3445-3453.e6. PubMed ID: 37468040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Long-Term Aspirin Desensitization in a Pilot With Aspirin-Exacerbated Respiratory Disease.
    Pacheco CS; Brooks RM; White KM
    Mil Med; 2023 Jul; 188(7-8):e2826-e2828. PubMed ID: 36383070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
    Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
    Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
    Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.
    Stevens WW; Peters AT; Hirsch AG; Nordberg CM; Schwartz BS; Mercer DG; Mahdavinia M; Grammer LC; Hulse KE; Kern RC; Avila P; Schleimer RP
    J Allergy Clin Immunol Pract; 2017; 5(4):1061-1070.e3. PubMed ID: 28286156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
    O'Brien EK; Jerschow E; Divekar RD
    Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortactin expression in nasal polyps of Aspirin-Exacerbated Respiratory Disease (AERD) patients.
    Brescia G; Parrino D; Nicolè L; Zanotti C; Lanza C; Barion U; Marino F; Marioni G
    Am J Otolaryngol; 2018; 39(3):293-298. PubMed ID: 29534838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does aspirin therapy after desensitization still have a role in treatment of chronic rhinosinusitis with nasal polyposis in the era of biologics?].
    Klimek F; Förster-Ruhrmann U; Hagemann J; Cuevas M; Gröger M; Klimek L
    HNO; 2024 Jul; 72(7):484-493. PubMed ID: 38409556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of NSAID-Exacerbated Respiratory Disease: has the time come for subphenotyping?
    Kowalski ML
    Curr Opin Pulm Med; 2019 Jan; 25(1):64-70. PubMed ID: 30489335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
    Walters KM; Waldram JD; Woessner KM; White AA
    Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
    Ertoy Karagol HI; Yilmaz O; Topal E; Ceylan A; Bakirtas A
    Int Forum Allergy Rhinol; 2015 May; 5(5):392-8. PubMed ID: 25755210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?
    Klimek L; Dollner R; Pfaar O; Mullol J
    Curr Allergy Asthma Rep; 2014 Jun; 14(6):441. PubMed ID: 24682773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
    Haque R; White AA; Jackson DJ; Hopkins C
    J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Samter's Triad to Aspirin-Exacerbated Respiratory Disease: Historical Perspective and Current Clinical Practice.
    Krouse HJ; Krouse JH
    ORL Head Neck Nurs; 2015; 33(4):14-8. PubMed ID: 26753248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
    Rajan JP; Wineinger NE; Stevenson DD; White AA
    J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R; Świerczyńska-Krępa M; Niżankowska-Mogilnicka E; Holtappels G; De Ruyck N; Sanak M; Derycke L; Van Crombruggen K; Bachert C; Pérez-Novo CA
    Cytokine; 2016 Jan; 77():157-67. PubMed ID: 26615369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory drug (NSAID) exacerbated respiratory disease phenotype: Topical NSAID and asthma control - A possible oversight link.
    Tan JHY; Hsu AAL
    Respir Med; 2016 Sep; 118():1-3. PubMed ID: 27578463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.